Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

BackgroundThis study aimed to employ plasma proteomics to investigate the molecular changes, pathway alterations, and potential novel biochemical markers associated with balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH).MethodsPre- and post-BP...

Full description

Bibliographic Details
Main Authors: Wei-Jie Xu, Shang Wang, Qian-Hao Zhao, Jia-Yi Xu, Xiao-Yi Hu, Su-Gang Gong, Jing He, Hong-Ling Qiu, Ci-Jun Luo, Jian Xu, Hui-Ting Li, Ze-Pu Li, Lan Wang, Yu Shi, Ya-Lin Zhao, Rong Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-05-01
Series:Frontiers in Immunology
Subjects:
chronic thromboembolic pulmonary hypertension
balloon pulmonary angioplasty
proteomics
asialoglycoprotein receptor 2
immune
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1402250/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1402250/full

Similar Items